Metropolitan Life Insurance Company (MetLife)’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,625
| Closed | -$21.9K | – | 1856 |
|
|
2024
Q1 | $21.9K | Buy |
1,625
+110
| +7% | +$1.49K | ﹤0.01% | 1810 |
|
|
2023
Q4 | $7.97K | Hold |
1,515
| – | – | ﹤0.01% | 2243 |
|
|
2023
Q3 | $5.97K | Hold |
1,515
| – | – | ﹤0.01% | 2382 |
|
|
2023
Q2 | $16.1K | Buy |
1,515
+255
| +20% | +$2.71K | ﹤0.01% | 2050 |
|
|
2023
Q1 | $10.5K | Sell |
1,260
-142
| -10% | -$1.18K | ﹤0.01% | 2142 |
|
|
2022
Q4 | $12.9K | Buy |
1,402
+77
| +6% | +$711 | ﹤0.01% | 2198 |
|
|
2022
Q3 | $17K | Hold |
1,325
| – | – | ﹤0.01% | 2099 |
|
|
2022
Q2 | $17.5K | Hold |
1,325
| – | – | ﹤0.01% | 2104 |
|
|
2022
Q1 | $27.9K | Sell |
1,325
-4,289
| -76% | -$90.3K | ﹤0.01% | 1929 |
|
|
2021
Q4 | $135K | Hold |
5,614
| – | – | ﹤0.01% | 2287 |
|
|
2021
Q3 | $143K | Hold |
5,614
| – | – | ﹤0.01% | 2310 |
|
|
2021
Q2 | $189K | Buy |
5,614
+1,834
| +49% | +$61.7K | ﹤0.01% | 2187 |
|
|
2021
Q1 | $147K | Hold |
3,780
| – | – | ﹤0.01% | 2222 |
|
|
2020
Q4 | $234K | Hold |
3,780
| – | – | ﹤0.01% | 1832 |
|
|
2020
Q3 | $127K | Sell |
3,780
-1,745
| -32% | -$58.4K | ﹤0.01% | 2082 |
|
|
2020
Q2 | $132K | Hold |
5,525
| – | – | ﹤0.01% | 2089 |
|
|
2020
Q1 | $127K | Buy |
5,525
+2,120
| +62% | +$48.5K | ﹤0.01% | 1880 |
|
|
2019
Q4 | $96.4K | Buy |
+3,405
| New | +$96.4K | ﹤0.01% | 2354 |
|